(1)
Keshandehghan, A.; Rostamian Tabari, A.; Panahi, Y.; Gardaneh, M. Acquisition of Doxorubicin Resistance Induces Breast Cancer Cell Migration and Epithelial-Mesenchymal Transition That Are Reversed by Shikonin-Metformin Synergy: Dox Resistance and BC Cell Migration. Arch Breast Cancer 2024, 11, 159-171.